It is indicated for the treatment of patients with congenital neutropenia, idiopathic neutropenia and neutropenia associated with bone marrow transplants or chemotherapy. Reference standards of Nartograstim API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
No Data Found
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
